Herein, we reveal that unlike chronic developmental Sox9 deletion, the acute and therapeutic elimination of Sox9 reduces overall cHCC-CCA tumor burden in Akt-YAP1 but not the Akt-NRAS model. The gene discussed is SOX9; the disease is neoplasm.